- India Glycols Limited (INDIAGLYCO) (Scrip Code 500201) received NCLT approval on 17 July 2026, sanctioning its proposed Scheme of Arrangement.
- The scheme will de‑merge the company into Ennature Bio Pharma Limited (EBL), which will take over the bio‑pharma business, and IGL Spirits Limited (ISL), which will inherit the spirits and bio‑fuel operations.
- The restructuring is being carried out under Sections 230‑232 of the Companies Act, 2013; it follows an earlier demerger intimation dated 3 July 2026.
- Shareholders need take no action now; the company will upload the NCLT order to the tribunal website and submit it to the exchanges.
India Glycols' demerger has been approved by the NCLT, which should lift the share price modestly as investors anticipate clearer business focus and value unlocking. The move is largely expected, so the upside is limited but positive.
Sign in for impact outlook, horizons, comparables, and full intelligence analysis.
Forecast from comparable, historic events. Not investment advice.
Frism is a financial information and news discovery platform. We provide factual summaries and data correlations for educational and informational purposes only. Frism does not provide investment advice, buy/sell recommendations, or directional market outlooks. Users should consult a qualified financial advisor before making any investment decisions.
Frism Computing (OPC) Private Limited
#74, 15TH CROSS, JP Nagar III Phase, Bangalore South, Bangalore 560078, Karnataka